Login

Kite Pharma Secures Loan, Tax Credit Commitments to Locate Drugmaking Facility in Urbana, Maryland

California Company Plans to Begin Commercial Production by End of 2021
Urbana Corporate Center. Photography: CoStar
Urbana Corporate Center. Photography: CoStar
By Casey Quam
June 27, 2019 | 4:21 P.M.

State and local officials in Maryland have endorsed more than $2.4 million in loans and tax incentives to woo Santa Monica, California-based drug company Kite Pharma to a site in Urbana.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE